MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04168ntm a2200337 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
12102116 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20211025113041.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
150118s2019 ua a f bm 000 0 eng | |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-EULC |
| Transcribing agency |
EG-EULC |
| Description conventions |
rda |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| Language code of summary or abstract/overprinted title or subtitle |
ara |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
572 |
| Item number |
A.F.S |
| Edition number |
22 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Ahmed, Sara Faisal Abdel Aal, |
| 9 (RLIN) |
33876 |
| Relator term |
author |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Association of CTRP and chemokine ligand-2 in Egyptian diabetic women with or without CAD / |
| Statement of responsibility, etc |
Sara Faisal Abdel Aal Ahmed, (Biochemistry teaching assistant, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt, B. Ph. Sci., Assuit University); Supervisors Prof. Dr. Hala Osman El- Mesallamy, (Professor of Biochemistry, Head of Biochemistry Department, Faculty of Pharmacy, Ain Shams University.), Prof. Dr. Mohamed Hesham El-Hefnawy, (Professor of Pediatric Endocrinology, Dean of the National Institute of Diabetes and Endocrinology.), Ass. Prof. Dr. Marwa Ismail Shabayek, (Assistant Professor of Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt.)<br/> |
| 246 15 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
ارتباط معدلات CTRP وكيموكاين ليجند - 2 في السيدات المصريات المصابات بداء السكري في وجود أو عدم وجود أمراض الشريان التاجي |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc |
2019 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
133 pages, 4 pages : |
| Other physical details |
illustrations (black and white) ; |
| Dimensions |
24 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Supervisors Prof. Dr. Hala Osman El- Mesallamy, (Professor of Biochemistry, Head of Biochemistry Department, Faculty of Pharmacy, Ain Shams University.), Prof. Dr. Mohamed Hesham El-Hefnawy, (Professor of Pediatric Endocrinology, Dean of the National Institute of Diabetes and Endocrinology.), Ass. Prof. Dr. Marwa Ismail Shabayek, (Assistant Professor of Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt.) |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Thesis (M.Sc.)-Ain Shams university, Faculty of pharmacy, Department of Biochemistry, 2019. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc |
Renal allograft survival requires multiple immunosuppressive drugs. This strategy<br/>may lead to gastric complications that necessitate gastro-protective medications,<br/>notably, proton pump inhibitors (PPI). This study aimed to compare the influence<br/>of pantoprazole and esomeprazole on serum cyclosporine trough levels (C0) in<br/>renal transplant recipients (RTR). A prospective, parallel, open-label trial was<br/>conducted on 47 adult RTR receiving cyclosporine doses adjusted to attain trough<br/>concentrations of 100 to 150 μg/L, mycophenolate mofetil (MMF) 750 mg<br/>q12 hour and prednisolone at 5 mg daily at Nasser Institute, Cairo, Egypt from<br/>January to September 2016. Patients were randomized into the esomeprazole<br/>group (25) or pantoprazole group (22) receiving the same dose (40 mg once daily).<br/>The study outcomes included clinical signs of rejection and renal function<br/>decline, assessed by elevations in serum creatinine, caused by cyclosporine level<br/>variations in either of the two study groups. Renal function, C0 and CBC measurements were measured at baseline and monthly for 6 months. The mean C0<br/>values were higher in the pantoprazole group than in the esomeprazole group in<br/>the sixth month only (P = .007). Serum creatinine level was lower in the sixth<br/>month than at baseline in the esomeprazole group (P = .004). There were no<br/>signs of rejection biochemical or clinical in any of the study groups. In conclusion,<br/>PPIs should be used with caution and doses should be titrated to reach the C0 targets in RTR, which is of more importance in pantoprazole than esomeprazole to<br/>avoid C0 level elevation or decline affecting the allograft function |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
Text in English, abstracts in English and Arabic. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biochemistry |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Diabetes |
| General subdivision |
Complications |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Coronary heart disease |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
DSpace electronic resource |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/5783">http://repository.fue.edu.eg/xmlui/handle/123456789/5783</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Thesis |
| Source of classification or shelving scheme |
Dewey Decimal Classification |